Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 22.

Nguyen, Vuong; Daien, Vincent; Guymer, Robyn; Young, Stephanie; Hunyor, Alex; Fraser-Bell, Samantha; Hunt, Adrian; Gillies, Mark C; Barthelmes, Daniel (2019). Projection of long-term visual acuity outcomes based on initial treatment response in neovascular age-related macular degeneration. Ophthalmology, 126(1):64-74.

Invernizzi, Alessandro; Teo, Kelvin; Nguyen, Vuong; Daniell, Mark; Squirrell, David; Barthelmes, Daniel; Gillies, Mark C (2018). Type 3 neovascularisation (retinal angiomatous proliferation) treated with antivascular endothelial growth factor: real-world outcomes at 24 months. The British Journal of Ophthalmology:Epub ahead of print.

Essex, Rohan W; Nguyen, Vuong; Daien, Vincent; Steinmann, Sarah; Walton, Richard; Gillies, Mark C; Barthelmes, Daniel (2018). Trainee-led versus specialist-led management of neovascular age-related macular degeneration: a registry-based study. The British Journal of Ophthalmology:Epub ahead of print.

Vaze, Anagha; Nguyen, Vuong; Daien, Vincent; Arnold, Jennifer J; Young, Stephanie H; Cheung, Chui M; Lamoureux, Ecosse; Bhargava, Mayuri; Barthelmes, Daniel; Gillies, Mark C; Fight Retinal Blindness Study Group (2018). Ranibizumab and Aflibercept for the Treatment of Pigment Epithelial Detachment in Neovascular Age-Related Macular Degeneration: Data from an Observational Study. Retina, 38(10):1954-1961.

Barthelmes, Daniel; Nguyen, Vuong; Walton, Richard; Gillies, Mark C; Daien, Vincent (2018). A pharmacoepidemiologic study of ranibizumab and aflibercept use 2013-2016. The Fight Retinal Blindness! Project. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 256(10):1839-1846.

Mehta, Hemal; Tufail, Adnan; Daien, Vincent; Lee, Aaron Y; Nguyen, Vuong; Ozturk, Mehmet; Barthelmes, Daniel; Gillies, Mark C (2018). Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors. Progress in Retinal and Eye Research, 65:127-146.

Daien, Vincent; Nguyen, Vuong; Morlet, Nigel; Arnold, Jennifer J; Essex, Rohan W; Young, Stephanie; Hunyor, Alex; Gillies, Mark C; Barthelmes, Daniel (2018). Outcomes and Predictive Factors After Cataract Surgery in Patients With Neovascular Age-related Macular Degeneration. The Fight Retinal Blindness! Project. American Journal of Ophthalmology, 190:50-57.

Ozturk, Mehmet; Harris, Martin L; Nguyen, Vuong; Barthelmes, Daniel; Gillies, Mark C; Mehta, Hemal (2018). Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept at fixed intervals as per UK licence. Clinical & Experimental Ophthalmology, 46(4):407-411.

Nguyen, Vuong; Daien, Vincent; Guymer, Robyn H; McAllister, Ian L; Morlet, Nigel; Barthelmes, Daniel; Gillies, Mark C (2018). Clinical and social characteristics associated with reduced visual acuity at presentation in Australian patients with neovascular age-related macular degeneration: a prospective study from a long-term observational data set. The Fight Retinal Blindness! Project. Clinical & Experimental Ophthalmology, 46(3):266-274.

Invernizzi, Alessandro; Nguyen, Vuong; Arnold, Jennifer; Young, Stephanie; Barthelmes, Daniel; Gillies, Mark C (2018). Early and Late Retinal Pigment Epithelium Tears after Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration. Ophthalmology, 125(2):237-244.

Irhimeh, Mohammad R; Hamed, Mohamed; Barthelmes, Daniel; Gladbach, Yvonne; Helms, Volkhard; Shen, Weiyong; Gillies, Mark C (2018). Identification of novel diabetes impaired miRNA-transcription factor co-regulatory networks in bone marrow-derived Lin-/VEGF-R2+ endothelial progenitor cells. PLoS ONE, 13(7):e0200194.

Daien, Vincent; Nguyen, Vuong; Essex, Rohan W; Morlet, Nigel; Barthelmes, Daniel; Gillies, Mark C; Fight Retinal Blindness Study Group (2018). Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration. Ophthalmology, 125(1):66-74.

Barthelmes, Daniel; Nguyen, Vuong; Daien, Vincent; Campain, Anna; Walton, Richard; Guymer, Robyn; Morlet, Nigel; Hunyor, Alex P; Essex, Rohan W; Arnold, Jennifer J; Gillies, Mark C; Fight Retinal Blindness Study Group (2018). Two Year Outcomes of "Treat And Extend" Intravitreal Therapy Using Aflibercept Preferentially for Neovascular Age-Related Macular Degeneration. Retina, 38(1):20-28.

Gillies, Mark C; Daien, Vincent; Nguyen, Vuong; Barthelmes, Daniel (2017). Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761). Ophthalmology, 124(3):e31-e32.

Barthelmes, Daniel; Campain, Anna; Nguyen, Phuc; Arnold, Jennifer J; McAllister, Ian L; Simpson, Judy M; Hunyor, Alex P; Guymer, Robyn; Essex, Rohan W; Morlet, Nigel; Gillies, Mark C; Fight Retinal Blindness! Project Investigators (2016). Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration. The British Journal of Ophthalmology, 100(12):1640-1645.

Gillies, Mark C; Nguyen, Vuong; Daien, Vincent; Arnold, Jennifer J; Morlet, Nigel; Barthelmes, Daniel (2016). Twelve-month outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration: data from an observational study. Ophthalmology, 123(12):2545-2553.

Essex, Rohan W; Nguyen, Vuong; Walton, Richard; Arnold, Jennifer J; McAllister, Ian L; Guymer, Robyn H; Morlet, Nigel; Young, Stephanie; Barthelmes, Daniel; Gillies, Mark C; Fight Retinal Blindness Study Group (2016). Treatment patterns and visual outcomes during the maintenance phase of treat-and-extend therapy for age-related macular degeneration. Ophthalmology, 123(11):2393-2400.

Rodrigues, Ian A; Sprinkhuizen, Sara M; Barthelmes, Daniel; Blumenkranz, Mark; Cheung, Gemmy; Haller, Julia; Johnston, Robert; Kim, Ramasamy; Klaver, Caroline; McKibbin, Martin; Ngah, Nor Fariza; Pershing, Suzann; Shankar, Dato; Tamura, Hiroshi; Tufail, Adnan; Weng, Christina Y; Westborg, Inger; Yelf, Catherine; Yoshimura, Nagahisa; Gillies, Mark C (2016). Defining a minimum set of standardized patient-centered outcome measures for macular degeneration. American Journal of Ophthalmology, 168:1-12.

Kim, Leah N; Mehta, Hemal; Barthelmes, Daniel; Nguyen, Vuong; Gillies, Mark C (2016). Metaanalysis of real-world outcomes of intravitreal ranibizumab for the treatment of neovascular age-related macular degeneration. Retina, 36(8):1418-1431.

Gillies, Mark C; Campain, Anna; Barthelmes, Daniel; Simpson, Judy M; Arnold, Jennifer J; Guymer, Robyn H; McAllister, Ian L; Essex, Rohan W; Morlet, Nigel; Hunyor, Alex P (2015). Long-term outcomes of treatment of neovascular age-related macular degeneration: data from an observational study. Ophthalmology, 122(9):1837-1845.

Arnold, Jennifer J; Campain, Anna; Barthelmes, Daniel; Simpson, Judy M; Guymer, Robyn H; Hunyor, Alex P; McAllister, Ian L; Essex, Rohan W; Morlet, Nigel; Gillies, Mark C (2015). Two-year outcomes of "treat and extend" intravitreal therapy for neovascular age-related macular degeneration. Ophthalmology, 122(6):1212-1219.

O'Day, Roderick F; Barthelmes, Daniel; Zhu, Meidong; Wong, Tien Y; McAllister, Ian L; Arnold, Jennifer J; Gillies, Mark C (2014). Intraocular pressure rise is predictive of vision improvement after intravitreal triamcinolone acetonide for diabetic macular oedema: a retrospective analysis of data from a randomised controlled trial. BMC Ophthalmology, 14:123.

This list was generated on Sun May 26 05:33:36 2019 CEST.